Bioretec Oy
OMXH:BRETEC
Cash Flow Statement
Cash Flow Statement
Bioretec Oy
| Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Net Income |
0
|
(6)
|
0
|
(2)
|
0
|
0
|
0
|
(5)
|
0
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
0
|
3
|
(0)
|
0
|
(0)
|
1
|
(0)
|
0
|
(0)
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(2)
|
0
|
(2)
|
(0)
|
(2)
|
(1)
|
(4)
|
(1)
|
(7)
|
|
| Cash from Operating Activities |
(2)
N/A
|
(2)
-11%
|
(2)
-4%
|
(2)
+5%
|
(2)
+6%
|
(3)
-55%
|
(5)
-31%
|
(5)
-13%
|
(7)
-31%
|
|
| Investing Cash Flow | ||||||||||
| Capital Expenditures |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
|
| Other Items |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
-99%
|
(0)
+31%
|
(0)
+4%
|
(0)
-22%
|
(0)
+49%
|
(1)
-238%
|
(1)
-34%
|
(0)
+32%
|
|
| Financing Cash Flow | ||||||||||
| Net Issuance of Common Stock |
0
|
9
|
0
|
0
|
10
|
10
|
0
|
6
|
16
|
|
| Net Issuance of Debt |
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other |
1
|
(2)
|
6
|
(2)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
|
| Cash from Financing Activities |
1
N/A
|
7
+1 159%
|
6
-20%
|
(3)
N/A
|
8
N/A
|
9
+18%
|
(0)
N/A
|
5
N/A
|
15
+182%
|
|
| Change in Cash | ||||||||||
| Net Change in Cash |
(2)
N/A
|
4
N/A
|
3
-31%
|
(5)
N/A
|
5
N/A
|
6
+6%
|
(5)
N/A
|
(1)
+88%
|
8
N/A
|
|
| Free Cash Flow | ||||||||||
| Free Cash Flow |
(2)
N/A
|
(3)
-29%
|
(2)
+10%
|
(3)
-5%
|
(3)
+3%
|
(4)
-42%
|
(5)
-40%
|
(6)
-16%
|
(7)
-23%
|
|